Advancing Value-Based Models of Care in Oncology
In pursuit of reduced healthcare costs and improved quality of care, the United States healthcare infrastructure is transitioning from a traditional fee-for-services (FFS) reimbursement model to value-based reimbursement. Value-based models seek to encourage cost-effective, high-quality care in a complex treatment environment. NCCN supports the advancement of value-based models in oncology to ensure people with cancer have access to the highest quality of care and health systems benefit from the most efficient use of resources possible. In order to manage costs while preserving optimal care, NCCN supports value-based models that:
NCCN strongly encourages the adoption of value models in oncology that adhere to the aforementioned principles to advance high-value cancer care.
NCCN supports the use of evidence-based, nationally recognized, guidelines to ensure people with cancer receive quality care while reducing cost and clinical burden. Recently the NCCN Quality & Outcomes Committee reviewed the existing quality landscape and identified contemporary, relevant, cancer quality and outcomes measures by both evaluating current validated measures and proposing new measure concepts to fill crucial gaps. This work will be a resource in quality measurement in oncology. In order to use quality measures to improve care and outcomes for people with cancer, NCCN affirms that:
In addition to the aforementioned statements, NCCN supports the alignment of similar, effective, measures in the quality space when and where possible.